Business Standard

BioNTech CEO confident Covid-19 vaccine will work on new UK variant

BioNTech's vaccine, developed together with US pharmaceutical company Pfizer, is authorised for use in more than 45 countries including Britain

Ugur Sahin, CEO of Biontech, gestures during an interview in Mainz, Germany, Wednesday, Nov. 27, 2019. (Andreas Arnold/dpa via AP)
Premium

Ugur Sahin, CEO of Biontech, gestures during an interview in Mainz, Germany, Wednesday, Nov. 27, 2019. (Andreas Arnold/dpa via AP)

AP | PTI
German pharmaceutical company BioNTech is confident that its coronavirus vaccine works against the new UK variant, but further studies are need to be completely sure, its chief executive said Tuesday.
 
The variant, detected mainly in London and the southeast of England in recent weeks, has sparked concern worldwide because of signs that it may spread more easily. While there is no indication it causes more serious illness, numerous countries in Europe and beyond have restricted travel from the UK as a result.
 
“We don’t know at the moment if our vaccine is also able to provide protection against this new

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in